Arcturus Therapeutics Holdings Inc. revenue breakdown overview

Arcturus Therapeutics Holdings Inc. revenue for the last year amounted to 152.31 M USD, the most of which — 152.31 M USD — came from its highest performing source at the moment, Messenger Ribonucleic Acid Medicines, the year earlier bringing 166.80 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Arcturus Therapeutics Holdings Inc. 152.31 M USD, and the year before that — 166.80 M USD.